How is Lymphoepithelioma in lung cancer treated?
Available treatments of pulmonary LELC include surgical resection, chemotherapy and radiotherapy, according to the different stages of the tumor (1). Furthermore, the optimal treatment and long-term follow-up results were limited due to the low rate of incidence.
How serious is lung cancer?
The lung cancer five-year survival rate (18.6 percent) is lower than many other leading cancer sites, such as colorectal (64.5 percent), breast (89.6 percent) and prostate (98.2 percent). The five-year survival rate for lung cancer is 56 percent for cases detected when the disease is still localized (within the lungs).
Who gets nasopharyngeal cancer?
Nasopharyngeal cancer can occur at any age, but it’s most commonly diagnosed in adults between the ages of 30 and 50. Salt-cured foods. Chemicals released in steam when cooking salt-cured foods, such as fish and preserved vegetables, may enter the nasal cavity, increasing the risk of nasopharyngeal carcinoma.
What were your first symptoms of nasopharyngeal cancer?
The first symptom of nasopharynx cancer is usually a lump in the upper part of the neck….Other signs and symptoms may include:
- Swelling of the neck.
- Persistent headaches.
- Nasal congestion (a blocked nose)
- Facial pain.
- Nosebleeds.
- Changes in hearing.
- Ringing in the ears.
- Many people have no symptoms.
How long do you live with nasopharyngeal cancer?
Survival rates can give you an idea of what percentage of people with the same type and stage of cancer are still alive a certain amount of time (usually 5 years) after they were diagnosed….5-year relative survival rates for nasopharyngeal cancer.
| SEER stage | 5-year relative survival rate |
|---|---|
| All SEER stages combined | 62% |
What does early stage lung cancer feel like?
Pain in the chest, back or shoulders that worsens during coughing, laughing or deep breathing. Shortness of breath that comes on suddenly and occurs during everyday activities. Unexplained weight loss. Feeling that you are tired or weak.
What was your first lung cancer symptom?
The most common symptoms of lung cancer are: A cough that does not go away or gets worse. Coughing up blood or rust-colored sputum (spit or phlegm) Chest pain that is often worse with deep breathing, coughing, or laughing.
Can nasopharyngeal cancer spread to lungs?
Most people with nasopharyngeal carcinoma have regional metastases. That means cancer cells from the initial tumor have migrated to nearby areas, such as lymph nodes in the neck. Cancer cells that spread to other areas of the body (distant metastases) most commonly travel to the bones, lungs and liver.
What is stage 4 nasopharyngeal carcinoma?
Stage IV nasopharyngeal cancer is divided into stages IVA and IVB. In stage IVA, (1) cancer has spread to the brain, the cranial nerves, the hypopharynx, the salivary gland in the front of the ear, the bone around the eye, and/or the soft tissues of the jaw.
What is the survival rate of nasopharyngeal carcinoma?
If the cancer is located only in the nasopharynx, the 5-year survival rate is 85%. If the cancer has spread to nearby tissues or organs and/or regional lymph nodes, the 5-year survival rate is 71%. If there is distant spread to other parts of the body, the 5-year survival rate is 49%.
Is pulmonary LELC a unique malignant tumor?
We found that pulmonary LELC is a unique malignant tumor. Middle-aged women and nonsmokers were comparatively predominated and CT features were relatively less-malignant. Careful evaluation of large surgical specimens combined with EBV detection was crucial in the pathologic diagnosis.
What is Lymphoepithelioma-like carcinoma of the lung (LELC)?
Lymphoepithelioma-like carcinoma (LELC) of the lung was first reported in 1987. In the past two decades, there have been just more than 150 cases reported in the literature. This uncommon but distinct form of non-small cell lung carcinoma has a predilection for young non-smoking Asians, without gender distinction.
What is the prognosis of pulmonary LELC with pulmonary embolism?
Consistent with previous reports, the prognosis of pulmonary LELC patients in our study was favorable [ 36, 37 ]. Due to the surprisingly high survival rate with only one case having died, we even failed to analyze the OS in LELC group, and just the PFS analysis was conducted.
Are there alternative mechanisms for the development of LELC beyond EBV driving?
The negative EBV infection cases suggest that there might be alternative mechanisms engaged in the development of LELC beyond EBV driving. Despite lacking an acknowledged treatment guideline, comprehensive therapies, such as surgery, chemotherapy and radiotherapy, are all preferable to LELC.